UniProt ID | RAD17_HUMAN | |
---|---|---|
UniProt AC | O75943 | |
Protein Name | Cell cycle checkpoint protein RAD17 | |
Gene Name | RAD17 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 681 | |
Subcellular Localization | Nucleus . Phosphorylated form redistributes to discrete nuclear foci upon DNA damage. | |
Protein Description | Essential for sustained cell growth, maintenance of chromosomal stability, and ATR-dependent checkpoint activation upon DNA damage. Has a weak ATPase activity required for binding to chromatin. Participates in the recruitment of the RAD1-RAD9-HUS1 complex and RHNO1 onto chromatin, and in CHEK1 activation. May also serve as a sensor of DNA replication progression, and may be involved in homologous recombination.. | |
Protein Sequence | MSKTFLRPKVSSTKVTDWVDPSFDDFLECSGVSTITATSLGVNNSSHRRKNGPSTLESSRFPARKRGNLSSLEQIYGLENSKEYLSENEPWVDKYKPETQHELAVHKKKIEEVETWLKAQVLERQPKQGGSILLITGPPGCGKTTTLKILSKEHGIQVQEWINPVLPDFQKDDFKGMFNTESSFHMFPYQSQIAVFKEFLLRATKYNKLQMLGDDLRTDKKIILVEDLPNQFYRDSHTLHEVLRKYVRIGRCPLIFIISDSLSGDNNQRLLFPKEIQEECSISNISFNPVAPTIMMKFLNRIVTIEANKNGGKITVPDKTSLELLCQGCSGDIRSAINSLQFSSSKGENNLRPRKKGMSLKSDAVLSKSKRRKKPDRVFENQEVQAIGGKDVSLFLFRALGKILYCKRASLTELDSPRLPSHLSEYERDTLLVEPEEVVEMSHMPGDLFNLYLHQNYIDFFMEIDDIVRASEFLSFADILSGDWNTRSLLREYSTSIATRGVMHSNKARGYAHCQGGGSSFRPLHKPQWFLINKKYRENCLAAKALFPDFCLPALCLQTQLLPYLALLTIPMRNQAQISFIQDIGRLPLKRHFGRLKMEALTDREHGMIDPDSGDEAQLNGGHSAEESLGEPTQATVPETWSLPLSQNSASELPASQPQPFSAQGDMEENIIIEDYESDGT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
21 | Ubiquitination | KVTDWVDPSFDDFLE CCCCCCCCCHHHHHH | 27.55 | 29967540 | |
32 | Ubiquitination | DFLECSGVSTITATS HHHHHCCCCEEEEEE | 2.34 | 29967540 | |
45 | Ubiquitination | TSLGVNNSSHRRKNG EEECCCCCCCCCCCC | 23.47 | 29967540 | |
54 | Phosphorylation | HRRKNGPSTLESSRF CCCCCCCCCHHHCCC | 47.20 | 28555341 | |
55 | Phosphorylation | RRKNGPSTLESSRFP CCCCCCCCHHHCCCC | 37.36 | 17494752 | |
55 | Ubiquitination | RRKNGPSTLESSRFP CCCCCCCCHHHCCCC | 37.36 | 29967540 | |
59 | Phosphorylation | GPSTLESSRFPARKR CCCCHHHCCCCCHHC | 28.68 | 28555341 | |
66 | Methylation | SRFPARKRGNLSSLE CCCCCHHCCCCHHHH | 33.41 | 115490083 | |
70 | Phosphorylation | ARKRGNLSSLEQIYG CHHCCCCHHHHHHHC | 36.56 | 23898821 | |
71 | Phosphorylation | RKRGNLSSLEQIYGL HHCCCCHHHHHHHCC | 38.81 | 23186163 | |
71 | Ubiquitination | RKRGNLSSLEQIYGL HHCCCCHHHHHHHCC | 38.81 | 29967540 | |
74 | Ubiquitination | GNLSSLEQIYGLENS CCCHHHHHHHCCCCC | 39.22 | 33845483 | |
81 | Phosphorylation | QIYGLENSKEYLSEN HHHCCCCCHHHHHCC | 19.93 | - | |
82 | Ubiquitination | IYGLENSKEYLSENE HHCCCCCHHHHHCCC | 63.06 | 29967540 | |
83 | Ubiquitination | YGLENSKEYLSENEP HCCCCCHHHHHCCCC | 52.07 | 29967540 | |
84 | Phosphorylation | GLENSKEYLSENEPW CCCCCHHHHHCCCCC | 21.18 | 23312004 | |
85 | Ubiquitination | LENSKEYLSENEPWV CCCCHHHHHCCCCCH | 5.62 | 29967540 | |
86 | Phosphorylation | ENSKEYLSENEPWVD CCCHHHHHCCCCCHH | 37.16 | 21815630 | |
94 | Ubiquitination | ENEPWVDKYKPETQH CCCCCHHHCCCCCHH | 45.62 | 29967540 | |
96 | Ubiquitination | EPWVDKYKPETQHEL CCCHHHCCCCCHHCH | 41.96 | 29967540 | |
107 | Ubiquitination | QHELAVHKKKIEEVE HHCHHHCHHHHHHHH | 49.52 | 29967540 | |
111 | Ubiquitination | AVHKKKIEEVETWLK HHCHHHHHHHHHHHH | 65.94 | 29967540 | |
118 | Ubiquitination | EEVETWLKAQVLERQ HHHHHHHHHHHHHHC | 28.47 | 29967540 | |
124 | Ubiquitination | LKAQVLERQPKQGGS HHHHHHHHCCCCCCE | 54.67 | 29967540 | |
141 | Ubiquitination | LITGPPGCGKTTTLK EEECCCCCCHHHHHH | 6.61 | 29967540 | |
143 | Ubiquitination | TGPPGCGKTTTLKIL ECCCCCCHHHHHHHH | 46.93 | 29967540 | |
152 | Ubiquitination | TTLKILSKEHGIQVQ HHHHHHHHHHCCCHH | 50.73 | 29967540 | |
160 | Ubiquitination | EHGIQVQEWINPVLP HHCCCHHHHHCCCCC | 52.01 | 33845483 | |
170 | Ubiquitination | NPVLPDFQKDDFKGM CCCCCCCCCCCCCCC | 56.50 | 29967540 | |
171 | Ubiquitination | PVLPDFQKDDFKGMF CCCCCCCCCCCCCCC | 60.29 | 33845483 | |
197 | Ubiquitination | QSQIAVFKEFLLRAT HHHHHHHHHHHHHHH | 40.74 | 29967540 | |
208 | Ubiquitination | LRATKYNKLQMLGDD HHHHHHCCHHHCCCC | 36.69 | 29967540 | |
210 | Ubiquitination | ATKYNKLQMLGDDLR HHHHCCHHHCCCCCC | 27.02 | 29967540 | |
221 | Ubiquitination | DDLRTDKKIILVEDL CCCCCCCEEEEEECC | 37.48 | 29967540 | |
222 | Ubiquitination | DLRTDKKIILVEDLP CCCCCCEEEEEECCC | 3.47 | 29967540 | |
249 | Ubiquitination | VLRKYVRIGRCPLIF HHHHHHHHCCCCEEE | 2.66 | 29967540 | |
293 | Phosphorylation | SFNPVAPTIMMKFLN CCCCCCHHHHHHHHH | 16.27 | 17924679 | |
304 | Phosphorylation | KFLNRIVTIEANKNG HHHHHCEEEEECCCC | 15.66 | 17924679 | |
308 | Ubiquitination | RIVTIEANKNGGKIT HCEEEEECCCCCEEE | 26.07 | 29967540 | |
319 | Ubiquitination | GKITVPDKTSLELLC CEEECCCCCHHHHHH | 33.66 | 29967540 | |
335 | Phosphorylation | GCSGDIRSAINSLQF CCCCCHHHHHHHHHC | 33.56 | - | |
335 | Ubiquitination | GCSGDIRSAINSLQF CCCCCHHHHHHHHHC | 33.56 | 29967540 | |
346 | Ubiquitination | SLQFSSSKGENNLRP HHHCCCCCCCCCCCC | 72.67 | 29967540 | |
359 | Phosphorylation | RPRKKGMSLKSDAVL CCCCCCCCCCHHHHH | 41.12 | 26074081 | |
362 | Phosphorylation | KKGMSLKSDAVLSKS CCCCCCCHHHHHCHH | 35.77 | - | |
367 | Phosphorylation | LKSDAVLSKSKRRKK CCHHHHHCHHHCCCC | 28.43 | - | |
410 | Phosphorylation | ILYCKRASLTELDSP HHHHCCCCCCCCCCC | 39.60 | 29255136 | |
412 | Phosphorylation | YCKRASLTELDSPRL HHCCCCCCCCCCCCC | 31.82 | 29255136 | |
416 | Phosphorylation | ASLTELDSPRLPSHL CCCCCCCCCCCCHHC | 25.25 | 21815630 | |
421 | Ubiquitination | LDSPRLPSHLSEYER CCCCCCCHHCHHHCC | 41.47 | 29967540 | |
494 | Phosphorylation | RSLLREYSTSIATRG HHHHHHHHHHHHHHC | 15.78 | 28857561 | |
500 | Ubiquitination | YSTSIATRGVMHSNK HHHHHHHHCCCCCCC | 27.04 | 29967540 | |
579 | Phosphorylation | MRNQAQISFIQDIGR CCCHHHHHHHHHHCC | 12.29 | 26270265 | |
586 | Ubiquitination | SFIQDIGRLPLKRHF HHHHHHCCCCHHHHH | 33.20 | 29967540 | |
597 | Ubiquitination | KRHFGRLKMEALTDR HHHHCHHHHHHHHCC | 33.08 | 29967540 | |
633 | Phosphorylation | EESLGEPTQATVPET HHHCCCCCCCCCCCE | 26.91 | - | |
646 | Phosphorylation | ETWSLPLSQNSASEL CEECCCCCCCCCCCC | 25.94 | 14871926 | |
656 | Phosphorylation | SASELPASQPQPFSA CCCCCCCCCCCCCCC | 40.22 | 11602352 | |
676 | Phosphorylation | ENIIIEDYESDGT-- CCEEEEECCCCCC-- | 12.44 | - | |
678 | Phosphorylation | IIIEDYESDGT---- EEEEECCCCCC---- | 34.80 | - | |
681 | Phosphorylation | EDYESDGT------- EECCCCCC------- | 40.19 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
633 | T | Phosphorylation | Kinase | ATM | Q13315 | PSP |
646 | S | Phosphorylation | Kinase | ATM | Q13315 | Uniprot |
646 | S | Phosphorylation | Kinase | ATR | Q13535 | Uniprot |
656 | S | Phosphorylation | Kinase | ATM | Q13315 | Uniprot |
656 | S | Phosphorylation | Kinase | ATR | Q13535 | Uniprot |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RAD17_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RFC2_HUMAN | RFC2 | physical | 14605214 | |
RFC3_HUMAN | RFC3 | physical | 14605214 | |
RFC4_HUMAN | RFC4 | physical | 14605214 | |
RFC5_HUMAN | RFC5 | physical | 14605214 | |
DPOE1_HUMAN | POLE | physical | 14500819 | |
DPOE2_HUMAN | POLE2 | physical | 14500819 | |
DPOE3_HUMAN | POLE3 | physical | 14500819 | |
DPOE4_HUMAN | POLE4 | physical | 14500819 | |
RAD9A_HUMAN | RAD9A | physical | 12578958 | |
HUS1_HUMAN | HUS1 | physical | 12578958 | |
RAD1_HUMAN | RAD1 | physical | 12578958 | |
RAD9A_HUMAN | RAD9A | physical | 10884395 | |
HUS1_HUMAN | HUS1 | physical | 10884395 | |
RAD1_HUMAN | RAD1 | physical | 10884395 | |
NH2L1_HUMAN | NHP2L1 | physical | 10593953 | |
RAD1_HUMAN | RAD1 | physical | 11418864 | |
CLSPN_HUMAN | CLSPN | physical | 16885023 | |
CADH1_HUMAN | CDH1 | physical | 20424596 | |
ANM6_HUMAN | PRMT6 | physical | 23455924 | |
UBP20_HUMAN | USP20 | physical | 24923443 | |
RFC4_HUMAN | RFC4 | physical | 28514442 | |
RFC3_HUMAN | RFC3 | physical | 28514442 | |
RFC2_HUMAN | RFC2 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"The human checkpoint Rad protein Rad17 is chromatin-associatedthroughout the cell cycle, localizes to DNA replication sites, andinteracts with DNA polymerase epsilon."; Post S.M., Tomkinson A.E., Lee E.Y.-H.P.; Nucleic Acids Res. 31:5568-5575(2003). Cited for: FUNCTION, PHOSPHORYLATION AT SER-646 AND SER-656, MUTAGENESIS OFSER-646 AND SER-656, AND INTERACTION WITH POLE. | |
"Phosphorylation of serines 635 and 645 of human Rad17 is cell cycleregulated and is required for G(1)/S checkpoint activation in responseto DNA damage."; Post S.M., Weng Y.-C., Cimprich K., Chen L.B., Xu Y., Lee E.Y.-H.P.; Proc. Natl. Acad. Sci. U.S.A. 98:13102-13107(2001). Cited for: FUNCTION, PHOSPHORYLATION AT SER-646 AND SER-656, INTERACTION WITHRFC4, AND MUTAGENESIS OF SER-191; SER-646 AND SER-656. | |
"ATR/ATM-mediated phosphorylation of human Rad17 is required forgenotoxic stress responses."; Bao S., Tibbetts R.S., Brumbaugh K.M., Fang Y., Richardson D.A.,Ali A., Chen S.M., Abraham R.T., Wang X.-F.; Nature 411:969-974(2001). Cited for: FUNCTION, INTERACTION WITH ATM; ATR AND RAD1, PHOSPHORYLATION ATSER-646 AND SER-656, AND MUTAGENESIS OF SER-646 AND SER-656. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-304, AND MASSSPECTROMETRY. |